74 research outputs found
Recommended from our members
Solid Freeform Fabrication of Ceramic Parts from Filler Loaded Preceramic Polymers
Manufacturing of ceramic parts was achieved by selective laser treatment of a
preceramic polymer (polysiloxane) loaded with ceramic filler powder (alumina). Thin layers
of polymer/filler powder mixture were sequentially cured with a CO2-laser (λ=10.6 µm)
thereby generating the geometrical shape of the part. Subsequently, the cured thermoset part
was annealed in nitrogen atmosphere at 600 to 1000 °C to convert the compact into a Si-OC/Al2O3 micro-composite material. Dimensional changes upon pyrolysis (∆l/l0 ≈ 3 %) can be
controlled by adjusting the polymer-to-filler ratio and the heat treatment conditions. The new
process is called Selective Laser Curing (SLC).Financial support of Fonds der Chemischen Industrie and Deutsche
Forschungsgemeinschaft is gratefully acknowledged.Mechanical Engineerin
GEO-INFORMATION TECHNOLOGIES FOR A MULTIMODAL ACCESS ON HISTORICAL PHOTOGRAPHS AND MAPS FOR RESEARCH AND COMMUNICATION IN URBAN HISTORY
This contribution shows ongoing interdisciplinary research of the project HistStadt4D, concerning the investigation and development of different multimodal access strategies on large image repositories. The first part of the presented research introduces different methods of access, where classical analogue access stands in contrast to digital access strategies such as online collections, Web3D, Augmented Reality (AR) and Virtual Reality (VR). We discuss the main persisting issues of libraries, advantages of digital methods, and different access tools. The second part shows technologies and workflows used to create various access possibilities. The photogrammetric and geo-informational work serves as a technical basis for a 3D WebGIS as well as multiple AR/VR applications, which require spatial oriented images, object coordinates, and further spatial data. We introduce a research environment that allows art historians spatial access to historical photography, integrating 3D/4D models with photographic documents of the respective architecture. For dissemination of research results in installations and museums, we present fully immersive VR as well as handheld AR applications allowing users a free exploration of historical photography in a spatial setting
Pore-scale Modeling of Viscous Flow and Induced Forces in Dense Sphere Packings
We propose a method for effectively upscaling incompressible viscous flow in
large random polydispersed sphere packings: the emphasis of this method is on
the determination of the forces applied on the solid particles by the fluid.
Pore bodies and their connections are defined locally through a regular
Delaunay triangulation of the packings. Viscous flow equations are upscaled at
the pore level, and approximated with a finite volume numerical scheme. We
compare numerical simulations of the proposed method to detailed finite element
(FEM) simulations of the Stokes equations for assemblies of 8 to 200 spheres. A
good agreement is found both in terms of forces exerted on the solid particles
and effective permeability coefficients
Hydrazones and Thiosemicarbazones Targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like Protease
The papain-like protease (PLpro) of SARS-CoV-2 is essential for viral propagation and, additionally, dysregulation of the host innate immune system. Using a library of 40 potential metal-chelating compounds we performed an X-ray crystallographic screening against PLpro. As outcome we identified six compounds binding to the target protein. Here we describe the interaction of one hydrazone (H1) and five thiosemicarbazone (T1-T5) compounds with the two distinct natural substrate binding sites of PLpro for ubiquitin and ISG15. H1 binds to a polar groove at the S1 binding site by forming several hydrogen bonds with PLpro. T1-T5 bind into a deep pocket close to the polyubiquitin and ISG15 binding site S2. Their interactions are mainly mediated by multiple hydrogen bonds and further hydrophobic interactions. In particular compound H1 interferes with natural substrate binding by sterical hindrance and induces conformational changes in protein residues involved in substrate binding, while compounds T1-T5 could have a more indirect effect. Fluorescence based enzyme activity assay and complementary thermal stability analysis reveal only weak inhibition properties in the high micromolar range thereby indicating the need for compound optimization. Nevertheless, the unique binding properties involving strong hydrogen bonding and the various options for structural optimization make the compounds ideal lead structures. In combination with the inexpensive and undemanding synthesis, the reported hydrazone and thiosemicarbazones represent an attractive scaffold for further structure-based development of novel PLpro inhibitors by interrupting protein-protein interactions at the S1 and S2 site
Deamidation drives molecular aging of the SARS-CoV-2 spike protein receptor-binding motif
The spike protein is the main protein component of the SARS-CoV-2 virion surface. The spike receptor-binding motif mediates recognition of the human angiotensin-converting enzyme 2 (hACE2) receptor, a critical step in infection, and is the preferential target for spikeneutralizing antibodies. Post-translational modifications of the spike receptor-binding motif have been shown to modulate viral infectivity and host immune response, but these modifications are still being explored. Here we studied asparagine deamidation of the spike protein, a spontaneous event that leads to the appearance of aspartic and isoaspartic residues, which affect both the protein backbone and its charge. We used computational prediction and biochemical experiments to identify five deamidation hotspots in the SARS-CoV-2 spike protein. Asparagine residues 481 and 501 in the receptor-binding motif deamidate with a half-life of 16.5 and 123 days at 37°C, respectively. Deamidation is significantly slowed at 4°C, indicating a strong dependence of spike protein molecular aging on environmental conditions. Deamidation of the spike receptor-binding motif decreases the equilibrium constant for binding to the hACE2 receptor more than 3.5-fold, yet its high conservation pattern suggests some positive effect on viral fitness. We propose a model for deamidation of the full SARS-CoV-2 virion illustrating how deamidation of the spike receptor-binding motif could lead to the accumulation on the virion surface of a nonnegligible chemically diverse spike population in a timescale of days. Our findings provide a potential mechanism for molecular aging of the spike protein with significant consequences for understanding virus infectivity and vaccine development.Fil: Lorenzo Lopez, Juan Ramiro. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Centro de Investigación Veterinaria de Tandil. Universidad Nacional del Centro de la Provincia de Buenos Aires. Centro de Investigación Veterinaria de Tandil. Provincia de Buenos Aires. Gobernación. Comision de Investigaciones Científicas. Centro de Investigación Veterinaria de Tandil; ArgentinaFil: Defelipe, Lucas Alfredo. European Molecular Biology Laboratory; Alemania. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales; ArgentinaFil: Aliperti Car, Lucio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales; ArgentinaFil: Niebling, Stephan. European Molecular Biology Laboratory; Alemania. Centre for Structural Systems Biology; AlemaniaFil: Custódio, Tânia F.. European Molecular Biology Laboratory; Alemania. Centre for Structural Systems Biology; AlemaniaFil: Löw, Christian. European Molecular Biology Laboratory; Alemania. Centre for Structural Systems Biology; AlemaniaFil: Schwarz, Jennifer J.. European Molecular Biology Laboratory; AlemaniaFil: Remans, Kim. European Molecular Biology Laboratory; AlemaniaFil: Craig, Patricio Oliver. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Departamento de Química Biológica; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Otero, Lisandro Horacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; ArgentinaFil: Klinke, Sebastian. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; ArgentinaFil: García Alai, María. European Molecular Biology Laboratory; Alemania. Centre for Structural Systems Biology; AlemaniaFil: Sánchez Miguel, Ignacio Enrique. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales; ArgentinaFil: Alonso, Leonardo Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Nanobiotecnología. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Nanobiotecnología; Argentin
Structure of the endocytic adaptor complex reveals the basis for efficient membrane anchoring during clatharin-mediated endocytosis
During clathrin-mediated endocytosis, a complex and dynamic network of protein-membrane interactions cooperate to achieve membrane invagination. Throughout this process in yeast, endocytic coat adaptors, Sla2 and Ent1, must remain attached to the plasma membrane to transmit force from the actin cytoskeleton required for successful membrane invagination. Here, we present a cryo-EM structure of a 16-mer complex of the ANTH and ENTH membrane-binding domains from Sla2 and Ent1 bound to PIP2 that constitutes the anchor to the plasma membrane. Detailed in vitro and in vivo mutagenesis of the complex interfaces delineate the key interactions for complex formation and deficient cell growth phenotypes demonstrate its biological relevance. A hetero-tetrameric unit binds PIP2 molecules at the ANTH-ENTH interfaces and can form larger assemblies to contribute to membrane remodeling. Finally, a time-resolved small-angle X-ray scattering study of the interaction of these adaptor domains in vitro suggests that ANTH and ENTH domains have evolved to achieve a fast subsecond timescale assembly in the presence of PIP2 and do not require further proteins to form a stable complex. Together, these findings provide a molecular understanding of an essential piece in the molecular puzzle of clathrin-coated endocytic sites
Massive X-ray screening reveals two allosteric drug binding sites of SARS-CoV-2 main protease
The coronavirus disease (COVID-19) caused by SARS-CoV-2 is creating tremendous health problems and economical challenges for mankind. To date, no effective drug is available to directly treat the disease and prevent virus spreading. In a search for a drug against COVID-19, we have performed a massive X-ray crystallographic screen of repurposing drug libraries containing 5953 individual compounds against the SARS-CoV-2 main protease (Mpro), which is a potent drug target as it is essential for the virus replication. In contrast to commonly applied X-ray fragment screening experiments with molecules of low complexity, our screen tested already approved drugs and drugs in clinical trials. From the three-dimensional protein structures, we identified 37 compounds binding to Mpro. In subsequent cell-based viral reduction assays, one peptidomimetic and five non-peptidic compounds showed antiviral activity at non-toxic concentrations. Interestingly, two compounds bind outside the active site to the native dimer interface in close proximity to the S1 binding pocket. Another compound binds in a cleft between the catalytic and dimerization domain of Mpro. Neither binding site is related to the enzymatic active site and both represent attractive targets for drug development against SARS-CoV-2. This X-ray screening approach thus has the potential to help deliver an approved drug on an accelerated time-scale for this and future pandemics
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
The coronavirus disease (COVID-19) caused by SARS-CoV-2 is creating tremendous human suffering. To date, no effective drug is available to directly treat the disease. In a search for a drug against COVID-19, we have performed a high-throughput X-ray crystallographic screen of two repurposing drug libraries against the SARS-CoV-2 main protease (M^(pro)), which is essential for viral replication. In contrast to commonly applied X-ray fragment screening experiments with molecules of low complexity, our screen tested already approved drugs and drugs in clinical trials. From the three-dimensional protein structures, we identified 37 compounds that bind to M^(pro). In subsequent cell-based viral reduction assays, one peptidomimetic and six non-peptidic compounds showed antiviral activity at non-toxic concentrations. We identified two allosteric binding sites representing attractive targets for drug development against SARS-CoV-2
X ray screening identifies active site and allosteric inhibitors of SARS CoV 2 main protease
The coronavirus disease COVID 19 caused by SARS CoV 2 is creating tremendous human suffering. To date, no effective drug is available to directly treat the disease. In a search for a drug against COVID 19, we have performed a high throughput x ray crystallographic screen of two repurposing drug libraries against the SARS CoV 2 main protease Mpro , which is essential for viral replication. In contrast to commonly applied x ray fragment screening experiments with molecules of low complexity, our screen tested already approved drugs and drugs in clinical trials. From the three dimensional protein structures, we identified 37 compounds that bind to Mpro. In subsequent cell based viral reduction assays, one peptidomimetic and six nonpeptidic compounds showed antiviral activity at nontoxic concentrations. We identified two allosteric binding sites representing attractive targets for drug development against SARS CoV
Recommended from our members
Analyzing the DMLS Process by a Macroscopic FE-Model
The presented macroscopic FE-model allows to analyze the thermal fields and the
resulting stress built up during Selective Laser Sintering. Process and material parameters are
focused on Direct Metal Laser Sintering (DMLS). The FE-model is introduced and the
assumptions for the model are given. Three different geometric models are discussed. The 3Dmodel shows the sintering of a single line, whereas 2D-models are used for longitudinal and
crosscuts of the sintering process. Aim of the investigation is a more basic knowledge about the
process, which will lead to a stabilization and optimization of the process.These investigations were financially supported by the DFG.Mechanical Engineerin
- …